Furthermore, Semionatto et al. engineered B16-F10 melanoma cells to express TNFSF ligands 4-1BBL and OX40L respectively, resulting in EVs formation that activated the proliferation of CD4+ T cells and inhibited the expression of Treg cells. This evidence concerns the gene CD4 and melanoma.